Ardsley Advisory Partners LP Jazz Pharmaceuticals PLC Transaction History

Ardsley Advisory Partners LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $738,220 - $1.01 Million	-7,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$95.68 - $121.88 $669,760 - $853,160	7,000 New	7,000 $772,000
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $13.4 Million - $15.7 Million	-110,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $869,550 - $1.25 Million	-7,500 Reduced 6.38%	110,000 $13.6 Million
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $1.37 Million - $1.53 Million	-8,500 Reduced 6.75%	117,500 $19.8 Million
Q2 2018 Aug 14, 2018	BUY	$146.33 - $183.18 $2.93 Million - $3.66 Million	20,000 Added 18.87%	126,000 $21.7 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $677,950 - $785,800	-5,000 Reduced 4.5%	106,000 $16 Million
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $4.46 Million - $5.11 Million	34,000 Added 44.16%	111,000 $14.9 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $2.42 Million - $2.65 Million	17,000 Added 28.33%	77,000 $11.3 Million
Q2 2017 Sep 21, 2017	BUY	N/A	60,000	60,000 $9.33 Million

516

57.8M

188K

110K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.54B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.